Pharmacy Program Updates Effective April 1, 2021
Effective April 1, 2021, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) will have changes to our pharmacy utilization management (UM) requirements.
Our UM requirements apply to all commercial members with pharmacy benefit coverage through Blue Cross NC. These changes do not affect State Health Plan, Federal Employee Program, Medicare Part D members or any self-funded employer groups that carve out pharmacy benefits to another pharmacy benefits manager (PBM).
Below is a summary of the changes:
New Requirements
Impacted Medications | Requirement |
---|---|
| Updated Quantity Limits on Oxycontin 60mg and 80mg from 4 tablets to 2 tablets per day. This aligns with other Oxycontin strengths. |
| These drugs will require Prior Authorization (only for members greater than 11 years old) |
| These drugs will require Prior Authorization & Step Therapy |
| These drugs will require Prior Authorization, Step Therapy, and Quantity Limits |
| This drug will require Prior Authorization & Quantity Limits |
| This drug will require Prior Authorization & Quantity Limits |
| These drugs will require Prior Authorization & Step Therapy |
| These drugs will require Quantity Limits (they have and will continue to require PA) |
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2024 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.